Philadelphia chromosome-positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature

American Journal of Hematology

Volumn 78, Issue 1, 2005, Pages 74-78

  Snyder, David S ^a   Stein, Anthony S ^a   O'Donnell, Margaret R ^a   Gaal, Karl ^a   Slovak, Marilyn L ^a   Forman, Stephen J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Ewing sarcoma; Philadelphia positive ALL; Secondary neoplasms

Indexed keywords

ASPARAGINASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; IMATINIB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; DRUG RESPONSE; EWING SARCOMA; HUMAN; LAMINECTOMY; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REMISSION; REVIEW; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; RADIATION INJURIES; SARCOMA, EWING'S; TIME FACTORS;

EID: 11144324944     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20251     Document Type: Review

References (29)

1. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2002;2:124-132.
2. Smith LM, Cox RS, Donaldson SS. Second cancers in long-term survivors of Ewing's sarcoma. Clin Orthop 1992;274:275-281.
3. Kuttesch JF Jr, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996;14(10):2818-2825.
4. Ferrari C, Bohling T, Benassi MS, et al. Secondary tumors in bone sarcomas after treatment with chemotherapy. Cancer Detect Prevent 1999;23(5):368-374.
5. Aparicio J, Munarriz B, Pastor M, et al. Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution. Oncology 1998;55(1):20-26.
6. Block AW, Carroll AJ, Hagemeijer A, et al. Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002;33:401-412.
7. Le Deley MC, Leblanc T, Shamsaldin A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique. J Clin Oncol 2003; 21(6):1074-1081.
8. Hunger SP, Sklar J, Link MP. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol 1992;10:156-163.
9. Dunst J, Ahrens S, Paulussen M, et al. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS studies. Int J Radiat Oncol Biol Phys 1998;42(2):379-384.
10. Rodriguez-Galindo C, Poquette CA, Marina NM, et al. Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors. J Pediatr Hematol Oncol 2000;22(4): 321-329.
11. Ishizawa S, Slovak ML, Popplewell LL, et al. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. Leukemia 2003;17(6):1091-1095.
12. Kapoor G, Bajpai S, Nair CN, Badrinath Y, Gladstone B, Advani SH. Calla-positive acute lymphoblastic leukemia after etoposide-based therapy for Ewing's sarcoma. Leuk Res 1995;19(10):771-772.
13. Al-Homaidhi AM, Patterson B, Rubin S, Lipton JH. Acute lymphoblastic leukemia with multiple cytogenetic abnormalities secondary to treatment of Ewing's sarcoma. Leuk Res 1999;23(6): 593-596.
14. Liou MC, Lin KH, Lu MY, Lin DT. Acute lymphoblastic leukemia occurring as a second malignant neoplasms in a child. J Formos Med Assoc 2002;101(7):502-504.
15. Andersen MK, Johansson B, Larsen SO, Pedersen-Bjergaard J. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Haematologica 1998;83(6):483-488.
16. Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: The University of Chicago Series. Blood 2003;102(1):43-52 (Epub ahead of print 6 Mar 2003).
17. Hattinger CM, Potschger U, Tarkkanen M, et al. Prognostic impact of chromosomal aberrations in Ewing's tumours. Br J Cancer 2002;86:1763-1769.
18. Pedersen-Bjergaard J, Brondum-Nielsen K, Karle H, Johansson B. Chemotherapy-related and late occurring Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors. Leukemia 1997;11:1571-1574.
19. Bauduer F, Ducout L, Dastugue N, Marolleau JP. Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: a report of three cases and a brief review of the literature. Leuk Lymphoma 2002;43(5):1057-1060.
20. Aguiar RCT, Sill H, Hochhaus A, Goldman JM, Cross NCP. Molecular investigation of secondary chronic myeloid leukemia. Blood 1996;88:2808-2809.
21. 131I treatment for thyroid carcinoma: a report of two cases and review of the literature. Clin Endocrinol (Oxf) 1995;43(5): 651-654.
22. Aguiar RCT, Beitler B, Dorlhiac-Llacer PE, Chamone DAF. Secondary chronic myelogenous leukemia: a diverse pathogenesis. Acta Haematol 1994;92:101-103.
23. Nakamura H, Inokuchi K, Hanawa H, et al. A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma. Ann Hematol 2000;79(7):396-401.
24. Mele L, Pagano L, Equitani F, et al. Lymphoid blastic crisis in Philadelphia chromosome-positive chronic granulocytic leukemia following high-grade non-Hodgkin's lymphoma. A case report and review of literature. Haematologica 2000;85(5):544-548.
25. Numata A, Shimoda K, Gondo H, et al. Therapy-related chronic myelogenous leukaemia following autologous stem cell transplantation for Ewing's sarcoma. Br J Haematol 2002;117:613-616.
26. Moss TJ, Strauss LC, Das L, Feig SA. Secondary leukemia following successful treatment of Wilms' tumor. Am J Pediatr Hematol Oncol 1989;11(2):158-161.
27. Stockschläder M, Fiedler W, Zander A, Weh HJ, Hossfeld DK. Philadelphia chromosome-positive secondary acute myeloid leukemia following high-dose chemotherapy with peripheral blood progenitor cell support for relapsed low-grade non-Hodgkin's lymphoma. Ann Hematol 1996;73:291-292.
28. Ohyashiki K, Kocova M, Ryan D, Rowe JM, Sandberg AA. Secondary acute myeloblastic leukemia with a Ph translocation in a treated Wegener's granulomatosis. Cancer Genet Cytogenet 1986;19(3-4):331-333.
29. Hattori M, Tanaka M, Yamazaki Y, Nakahara Y, Tsushita K, Utumi M. Detection of major and minor bcr/abl fusion gene transcripts in a patient with acute undifferentiated leukemia secondary to treatment with an alkylating agent. Leuk Res 1995;19:389-396.